Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
March 31, 2024 0.3163M
December 31, 2023 0.4836M
September 30, 2023 0.4113M
June 30, 2023 0.5817M
March 31, 2023 0.7767M
December 31, 2022 0.439M
September 30, 2022 0.4288M
June 30, 2022 0.3658M
March 31, 2022 0.3347M
December 31, 2021 0.397M
September 30, 2021 0.0907M
June 30, 2021 0.0245M
March 31, 2021 0.018M
Date Value
December 31, 2020 0.0517M
September 30, 2020 0.0304M
June 30, 2020 0.0089M
March 31, 2020 0.2401M
June 30, 2019 0.1764M
March 31, 2019 0.3934M
December 31, 2018 0.1159M
September 30, 2018 0.5282M
June 30, 2018 0.1194M
March 31, 2018 0.2759M
December 31, 2017 0.3682M
September 30, 2017 0.2463M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
AMN Healthcare Services, Inc. --
Agilent Technologies, Inc. 120.00M
Bio-Rad Laboratories, Inc. 61.20M
Bruker Corp. 94.30M
Azenta, Inc. 8.853M